| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/21/2010 | CA2728094A1 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/20/2010 | EP2145897A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/20/2010 | EP2145889A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 01/20/2010 | EP2145617A1 Gel formulation |
| 01/20/2010 | EP2145615A1 Skin-lightening agent containing equol compound as active ingredient |
| 01/20/2010 | EP2144872A2 Low calcemic, highly antiproliferative, analogs of calcitriol |
| 01/20/2010 | EP2144625A1 A controlled release enzymatic composition and methods of use |
| 01/20/2010 | EP1658064B1 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1443970B1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 01/20/2010 | EP1117419B1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/20/2010 | EP1059940B1 topical compositions comprising an alpha 1-adrenergic blocker FOR TREATING PAINFUL CONDITIONS OF THE ANAL REGION |
| 01/20/2010 | CN101628905A C-aryl glucoside SGLT2 inhibitors and method |
| 01/20/2010 | CN100582235C Use of krev alcohol in preparing tyrosinase inhibitor |
| 01/20/2010 | CN100582121C 胸腺素β4衍生物及其应用 Thymosin β4 derivative and its applications |
| 01/20/2010 | CN100582103C 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581567C Vaginitis lotion preparation method |
| 01/20/2010 | CN100581502C Human soft tissue filler for injection, and its preparation method |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7648968 Using water insoluble microparticulate glucans comprising branched beta -(1,3)(1,6) glucan, essentially free of unbranched beta -(1,3)(1,6) glucan and non-glucan components |
| 01/19/2010 | US7648710 Formulation containing phosphate derivatives of electron transfer agents |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/19/2010 | CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 01/19/2010 | CA2393466C Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2235412C Pharmaceutical composition containing an activin or inhibin stimulator |
| 01/14/2010 | WO2010006261A1 Methods for inducing stem cell migration and specialization with ec-18 |
| 01/14/2010 | WO2010006231A1 Treating inflammation and related conditions with irindalone |
| 01/14/2010 | WO2010006184A2 Small-molecule inhibitors of hif and angiogenesis |
| 01/14/2010 | WO2010006172A2 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | WO2010006169A2 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 01/14/2010 | WO2010006135A2 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | WO2010006125A2 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | WO2010006123A2 19-nor-vitamin d analogs with 1,2-dihydrofuran ring |
| 01/14/2010 | WO2010006121A2 19-nor-vitamin d analogs with 3,2-dihydrofuran ring |
| 01/14/2010 | WO2010006117A2 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005403A1 Dermatological composition for use in the treatment and/or prevention of skin diseases |
| 01/14/2010 | WO2010005012A1 Apolactoferrin-containing composition |
| 01/14/2010 | WO2010004982A1 Ameliorating or therapeutic agent for dyslipidemia |
| 01/14/2010 | WO2010004816A1 Inhibitor of degranulation of mast cell |
| 01/14/2010 | WO2010004367A1 Use of a mixture of superoxide dismutase and catalase for treating pruritus and alleviating its symptoms |
| 01/14/2010 | WO2010004339A1 Processes for the preparation of crystalline forms of sunitinib malate |
| 01/14/2010 | WO2010004303A1 Compositions for the treatment of hair loss |
| 01/14/2010 | WO2010004016A1 Use of phenoxyalkylamines in cosmetic and/or dermatological compositions |
| 01/14/2010 | WO2010003568A1 Topical composition for the treatment of actinic keratosis |
| 01/14/2010 | WO2009138705A3 Compositions based on polymer/hydrogen peroxide complexes and uses thereof |
| 01/14/2010 | US20100010084 High penetration prodrug compositions of retinoids and retinoid-related compounds |
| 01/14/2010 | US20100010052 Topical composition comprising a dihydropyridine calcium antagonist |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009947 2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009946 2-Methylene-19,26-Dinor-(20R,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009945 3,2-dihydrofuran-1 alpha ,25-dihydroxy-19-nor-vitamin D3; prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases; osteoporosis |
| 01/14/2010 | US20100009944 19-Nor-Vitamin D Analogs with 1,2-Dihydrofuran Ring |
| 01/14/2010 | US20100009942 2-Methylene-(17Z)-17(20)-Dehydro-19,21-Dinor-Vitamin D Analogs |
| 01/14/2010 | US20100009941 2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009940 2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009927 Anti-Inflammatory and Anti-Allergy Extracts from Nettle |
| 01/14/2010 | US20100009903 Methods for Promoting Wound Healing and/or Reducing Scar Formation |
| 01/14/2010 | US20100008873 Use of benzotriazole derivatives for photostabilisation |
| 01/14/2010 | US20100008868 Sustained remission of atopic dermatitis |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2730385A1 Treating inflammation and related conditions with irindalone |
| 01/14/2010 | CA2730257A1 2-methylene-19,26-dinor-(20s,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730254A1 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | CA2730248A1 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730247A1 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730244A1 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730108A1 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 01/14/2010 | CA2730079A1 Processes for the preparation of crystalline forms of sunitinib malate |
| 01/14/2010 | CA2729974A1 Topical composition for the treatment of actinic keratosis |
| 01/14/2010 | CA2724318A1 Compositions for the treatment of hair loss |
| 01/13/2010 | EP2143427A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/13/2010 | EP2143421A1 Topical composition for the treatment of actinic keratosis |
| 01/13/2010 | EP2142669A2 Sirtuin based methods and compositions for treating b- catenin-related conditions |
| 01/13/2010 | EP2142202A2 Cleome spinosa extract used in pharmaceutical preparations and cosmetic compositions |
| 01/13/2010 | EP2142200A1 Homeopathy-based formulation |
| 01/13/2010 | EP2142171A2 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof |
| 01/13/2010 | EP1487453B1 N- ¬(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl methyl -2- 3-¬(methylsulphonyl)amino phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions |
| 01/13/2010 | EP1255725B1 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/13/2010 | CN100579974C Podocarpus extract and its preparation method |
| 01/13/2010 | CN100579582C Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the preparation of medicament for treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of aller |
| 01/13/2010 | CN100579561C Oral Chinese medicine composition for treating urtica |
| 01/13/2010 | CN100579553C Internal-applied Chinese medicine composition for treating chloasma |
| 01/13/2010 | CN100579545C Health-care wine with sleeping improving and beauty functions and its preparing process |
| 01/13/2010 | CN100579537C Centella soft capsule and its preparing method |
| 01/13/2010 | CN100579531C Medicine composition for treating psoriasis |
| 01/13/2010 | CN100579521C Fatty acid analogues for the treatment of proliferative skin disorders |
| 01/13/2010 | CN100579517C 'Longxuejie' soft capsule and preparation method thereof |
| 01/12/2010 | US7645796 Amino acid composition promoting collagen synthesis |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | US7645764 Kinase inhibitors and methods for using the same |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |